David F Jarrard
Professor
Urology
University of Wisconsin
United States of America
Biography
Dr. Jarrard did his MD from University of Virginia School of Medicine, Charlottesville, VA, 1989. He is Junior Residency in General Surgery, University of Chicago, Chicago, IL, 1989-1990 Residency in Urology, University of Chicago, Chicago, IL, 1990-1994. He is Fellow in Urologic Oncology, American Foundation for Urologic Disease, Johns Hopkins University, Baltimore, MD, 1994-1996. Clinical Specialties Dr. Jarrard is board certified by the American Board of Urology and has completed a fellowship in Urologic Oncology. He specializes in all aspects of urologic oncology with an emphasis on prostate cancer diagnosis and treatment including robotics.
Research Interest
Dr. Jarrard has a joint appointment with the University of Wisconsin Comprehensive Cancer Center, and his clinical research emphasizes developing novel diagnostics and new therapies for genitourinary cancers. He has an active basic science laboratory and is funded through the National Institutes of Health and Department of Defense to examine genetic and epigenetic alterations in prostate cancer.
Publications
-
Wang JH, Downs TM, Jason Abel E, Richards KA, Jarrard DF. Prostate Biopsy in Active Surveillance Protocols: Immediate Re-biopsy and Timing of Subsequent Biopsies. Curr Urol Rep 2017 Jul; 18(7):48. [PubMed ID: 28589399]
-
Damaschke N, Yang B, Bhusari S, Avilla M, Zhong W, Blute ML, Huang W, Jarrard DF. Loss of IGF2 gene imprinting in murine prostate promotes widespread neoplastic growth. Cancer Res. 2017 Aug 03. [PubMed ID: 28775169]
-
Maciolek KA, Jarrard DF, Abel EJ, Best SL. Systematic Assessment Reveals Lack of Understandability for Prostate Biopsy Online Patient Education Materials. Urology 2017 Aug 02. [PubMed ID: 28780302]
